See Vaishnav, supra note 162, at 598 ("While at least one court has considered the role of patients as consumers, the more prevalent view seems to be that the patient's preferences for prescription drugs are irrelevant to the demand for such drugs") (citing In re
Cardizem CD Antitrust Litig., 105 F.
The leading case giving pay-for-delay settlements per se treatment is the Sixth Circuit's decision in In re
Cardizem CD Antitrust Litigation.
Christopher-Stine said she recommends starting with the calcium-channel blocker diltiazem (
Cardizem) at an average dosage of 360 mg/day (range, 120-480 mg/ day), followed by colchicine (Colcrys) 0.6 mg/day, working up to 1.8 mg/ day.
Videx EC (United Bristol Myers Squibb States and Canada) Co./Bristol Myers Squibb Canada Diltiazem
Cardizem CD 360 mg BTA Pharmaceuticals Inc.
The patient took digoxin, warfarin and
cardizem for her atrial fibrillation and glipizide and metformin for diabetes mellitus.
(160.) It is appropriate to ban a pay-for-delay settlement when the agreement appears to exceed the scope of the patent, such as in In re
Cardizem, in which the first ANDA-filer agreed not to license the 180-day period of first-mover exclusivity.
The most effective blood pressure lowering drugs--calcium channel blockers--include
Cardizem and Procardia.
(Corona CA) received approval for a generic equivalent of the blood pressure drug
Cardizem LA.
16 March 2010 - US-based specialty pharmaceutical company Watson Pharmaceuticals Inc (NYSE: WPI) announced yesterday that its subsidiary Watson Laboratories has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's
Cardizem LA product.
manufactured and marketed the prescription drug
Cardizem CD, used to
Others, such as verapamil (Isoptin) and diltiazem (
Cardizem) are more likely to be used if it is necessary to lower the heart rate.
The first case, In re
Cardizem CD Antitrust Litigation, (97) involved a drug used to treat angina and hypertension and to prevent heart attacks and strokes.
She was, however, on 13 outpatient medications: Lantus, Singulair, aspirin, Niferex, Toprol, Lasix, Zestril, Lipitor, propoxyphene, Aldactone, Plavix, Prilosec, and
Cardizem, as well as home oxygen.
